The best rechargeable hearing aids of 2025, according to experts
When the Food and Drug Administration greenlighted over-the-counter (OTC) hearing aids in 2022, they unlocked a new era in hearing technology. What was once a prescription-only market with eye-watering prices has become an accessible solution for millions of Americans. There are now quality options starting at just a few hundred dollars, with both OTC hearing aids and prescription models offering impressive tech that was unimaginable a few years ago.
The modern hearing aid market now features sleek, nearly invisible devices with smartphone apps; Bluetooth connectivity for streaming calls and music directly to your ears; advanced noise cancellation for crowded environments; and automatic adjustments that optimize sound as you move between different settings. The days of beige, clunky devices are gone, replaced by stylish options in various colors and designs.
Among the biggest game changers? Rechargeable technology that eliminates those tiny, expensive disposable batteries forever.
"A rechargeable hearing aid can be advantageous," says Dr. Cory Bovenzi, an otolaryngologist (head-and-neck surgeon). "You do not have to buy the specialized and sometimes hard-to-find batteries over and over again to continue using your aids," he explains. Dr. Michael Yong, an otolaryngologist and neurorhinologist at Pacific Neuroscience Institute, adds that these hearing aids eliminate the frustrating challenge of handling the tiny batteries of traditional models. No more squinting at microscopic symbols or fumbling with delicate battery doors — a significant benefit for those with dexterity challenges or vision issues.
Working with leading audiologists and ENT specialists, we identified what truly matters in hearing technology. After extensive research analyzing top-rated models for battery life, ease of use, sound quality and overall value, we've assembled this guide to the best rechargeable hearing aids of 2025.
Best rechargeable hearing aid overall
Other rechargeable hearing aids we recommend for 2025
Types of hearing aids
Factors to consider when buying a hearing aid
How we chose the best rechargeable hearing aids
Other hearing aids we considered
FAQs
Meet our experts
Update, May 7, 2025: We checked all product prices and availability. Our No. 1 choice for the best rechargeable hearing aid has been updated, and we've added four options that didn't make our top picks.
(back to top)
(back to top)
Feeling overwhelmed by all the hearing aid options? You're not alone! Today's hearing technology comes in more shapes and sizes than ever before, each with unique advantages for different lifestyles and hearing needs. To help cut through the confusion and help you discover which hearing aid style might be your perfect match, here are the most common types of hearing aid styles:
Behind-the-ear (BTE): These larger, powerful models sit behind your ear with a tube connecting to an earmold. They're easier to handle, adjust and clean. While more visible than other options, they have the most features, the longest battery life and are suitable for severe hearing loss.
Receiver-in-canal (RIC): The speaker of RIC hearing aids sits inside your ear canal, while the processor hides behind your ear. They offer excellent sound quality, are less visible than BTE models and work for mild to severe hearing loss. Their versatile design makes them suitable for many.
In-the-ear (ITE): Custom-molded to fill the outer portion of your ear, these one-piece units are easier to handle than smaller styles but are more discreet than BTE models. Great for mild to severe hearing loss, and they often include directional microphones for better hearing in noisy places.
In-the-canal (ITC): These partially fit into your ear canal with a small portion showing in the outer ear. More discreet than ITE models, they work well for mild to moderate hearing loss but have smaller batteries and fewer features due to size constraints.
Completely-in-canal (CIC): If you're looking for the most discreet hearing aids, CIC is an appealing option. They sit deep in your ear canal, making them nearly invisible. While aesthetically appealing, they're harder to adjust, accommodate fewer features and aren't suitable for severe hearing loss. Furthermore, their tiny batteries need more frequent changing, and they're not recommended for those with dexterity issues.
(back to top)
Besides the type of hearing aid, there are other elements to mull over when buying one. Most importantly, you'll want one that suits your level of hearing loss, needs and lifestyle.
At baseline, "The goal is that they can turn sounds up loud enough to optimize audibility for an individual with hearing loss," says Meaghan Reed, Director of Clinical Audiology at Mass Eye and Ear. "The amount of volume that an individual needs to help them communicate and meet their listening needs varies person to person." Beyond that, there are some specifics to keep in mind.
Hearing aid prices range dramatically from a few hundred dollars for basic models to several thousand for premium tech. As you shop, bear in mind that many prescription hearing aids are priced individually, meaning a "$2,000 price tag" could be $4,000 for both ears. In contrast, most over-the-counter options advertise the full pair price upfront. This difference can create sticker shock if you're not paying attention to how prices are listed.
MBefore making any purchase, call your insurance provider to check your specific coverage. Also worth noting: any hearing aids qualify as FSA/HSA-eligible expenses, allowing you to use tax-advantaged health care funds to offset costs.
Your hearing needs should drive your decision between prescription and over-the-counter options. OTC hearing aids have improved dramatically, offering quality and features that rival many prescription devices, often at significantly lower prices.
The key difference? Personalization. Prescription aids require professional fitting by an audiologist who tailors them to your unique hearing profile. This makes them ideal for complex or severe hearing loss, where subtle adjustments make a big difference. The professional relationship also provides ongoing support and adjustments as your hearing changes.
OTC devices work best for those with mild to moderate hearing loss who prefer convenience and cost savings over maximum customization.
Prescription hearing aids offer the white-glove treatment. Simply show up at your audiologist's office, and they handle everything from programming to fitting, explaining every button and feature while making precise adjustments for your specific hearing profile.
With OTC options, you're in the driver's seat. Many come with user-friendly smartphone apps that walk you through self-administered hearing tests and personalization. While this DIY approach gives you flexibility and saves money, there's a learning curve that some folks find challenging. However, many OTC brands now include remote support options, allowing a professional audiologist to connect virtually to your devices and make adjustments without an office visit.
If technology makes you uneasy or you have complex hearing needs, consider brands offering robust setup assistance, or go the prescription route.
Most modern hearing aids now connect to smartphone apps for easy adjustments on the go. These apps let you discreetly change volume, switch between environments and track battery life without touching your ears.
If you're comfortable with technology, look for models advertising app compatibility to transform your hearing experience. Not tech-savvy? Many excellent options still offer simple physical controls instead of digital features.
Bluetooth-compatible hearing aids do double-duty as wireless earbuds, streaming phone calls, music, podcasts and TV audio directly to your ears. This connection eliminates background noise and delivers clearer sound exactly where needed.
Before buying, check compatibility specifics. Some hearing aids work seamlessly with Apple devices but have limited Android functionality (or vice versa). Review which smartphones and tablets pair with your chosen model to avoid frustration later. Many manufacturers list compatibility details on their product pages, saving you the headache of returns or exchanges.
Noise cancellation technology helps filter out background chaos in busy environments, while directional microphones focus on conversations directly in front of you. Some models even include relaxation modes that play calming sounds to help manage tinnitus.
These bells and whistles typically increase the price tag, so prioritize features that match your specific lifestyle needs. Often overlooked but equally valuable are generous trial periods and comprehensive support packages. The ability to test-drive your hearing aids in real-world situations might be more beneficial than fancy technical features you rarely use.
(back to top)
Finding the best rechargeable hearing aids meant scrutinizing what really matters to people with hearing loss. We started by consulting audiologists and ENT specialists (ear, nose and throat doctors) to understand what separates invaluable devices from expensive disappointments. Armed with their expert insights, we identified critical features like battery longevity, sound quality and ease of use.
We then researched countless top-rated options through their paces — both OTC models you can grab without a prescription and premium aids available through hearing professionals. Our team considered performance in challenging real-world environments, sound quality, battery life and how intuitive the controls were. We also considered practical factors like warranty coverage, availability of professional support and real user experiences. The winners represent the perfect balance of technology, convenience and reliability, without unnecessary bells and whistles that drive up costs without improving quality of life.
(back to top)
Eargo 7: This hearing aid inserts completely into your ear canal for a virtually invisible experience. For the $2,700 price point, it features sophisticated Sound Adjust+ technology to seamlessly adjust independently. These OTC hearing aids have near-prescription-quality performance and have lifetime support from hearing professionals.
Widex Moment CIC: You can enjoy incredible sound quality delivered with unprecedented speed with these hearing aids, thanks to their revolutionary ZeroDelay technology. There are also impressive connectivity features, including Bluetooth streaming, hands-free iPhone calling and a convenient "find my hearing aid" function in the companion app. The only catch? Be prepared to invest between $3,000 and $7,000 to experience these premium Widex Moment aids.
Horizon Go IX: Perfect for active adults with mild to profound hearing loss, the Go IX uses dual sound processors to separate speech from background noise, creating better spatial awareness in crowded rooms. Plus, the intuitive smartphone app lets you discreetly adjust settings on the go. At around $6,000 per pair, they offer impressive technology, but the price point may be inaccessible for many.
(back to top)
Standard Medicare plans (Parts A and B) don't cover hearing aids. Although frustrating, the silver lining is that they typically cover necessary diagnostic hearing tests and screenings that help determine your needs.
However, as Yong advises, many Medicare Advantage plans (Part C) offer partial coverage for hearing aids, which could save you hundreds or even thousands of dollars. It's worth calling your specific plan provider to ask about your hearing aid benefits, as many people don't realize they have coverage available.
Rechargeable hearing aids are the smartphone of hearing devices. Charge them at night, and they're ready to go in the morning. "Rechargeable hearing aids have a charging device that can recharge an internal nonremovable battery in the hearing aids," Bovenzi explains. The beauty of this technology is in its simplicity for daily use, especially for those with arthritis or vision challenges. He adds that these hearing aids are often more convenient than traditional options, as they're easy to use and eliminate the need to buy new batteries or change the small batteries out when the old ones expire.
Rechargeable devices vary in how long they can hold a charge; it's usually recommended that you recharge your hearing aids every night so they're ready to use all day without interruption. For hearing aids with shorter battery lives, you can simply pop them into their charger during quiet moments, like watching TV or taking a nap, just like you do with your cellphone.
It comes down to your lifestyle and preferences. "Rechargeable hearing aids usually have several advantages, one of the main ones being that you generally don't have to remove the battery to replace it, and you can simply recharge the device by putting it in a docking area," Yong says.
For many folks, this convenience factor is huge as there's no more fumbling with tiny batteries or making emergency drugstore runs when batteries die during dinner with the grandkids. Plus, there's a hidden benefit that many don't consider: "The other big advantage, I would say, is that they lend themselves to routine, which can be really important. Users will usually charge the hearing aids every day at a similar time, which reduces the chance of suddenly running out of battery," Yong says.
The potential downside? Rechargeable models typically cost more upfront, although you'll save on battery expenses. If you're budget-conscious, don't worry! "These devices are generally getting cheaper over time," Yong says. And many users find the higher initial investment well worth the daily convenience, especially if you have dexterity or vision challenges.
Battery life varies dramatically across models. Some premium rechargeable hearing aids can power through up to 51 hours on a single charge, enough for a long weekend without worrying, while budget-friendly options might give out after just 10 hours. Higher price often correlates with longer battery life, but there are exceptions worth exploring.
Before fixating on maximum battery life, think about your daily needs. If you typically wear hearing aids from morning coffee until dinner, then a nine-hour battery might be perfectly adequate. Consider your lifestyle: Do you regularly forget to charge electronics? Do you frequently take long trips away from power sources? Are you often out all day and into evening social events?
The perfect balance is finding a hearing aid with enough battery life for your typical day, plus a small buffer, without paying extra for capacity you'll rarely use.
Today's hearing aid batteries have impressive staying power. "These batteries can be recharged about 500 to 1,000 times, meaning these can last for a few years before they need to be replaced," Bovenzi says.
To put that in perspective, if you charge your hearing aids nightly, that's anywhere from 18 months to nearly three years of use before needing a battery replacement. This long lifespan makes rechargeable hearing aids increasingly cost-effective, especially when you factor in the hundreds of disposable batteries you won't need to purchase.
Yes, cheap hearing aids work — although they may not last as long as their pricier counterparts, and they come with other trade-offs. "As with many other things, when it comes to hearing aids, you get what you pay for," Bovenzi says.
Today's premium hearing aids go far beyond simple amplification. "There is a lot of sophisticated technology involved in hearing aid development," Bovenzi explains, noting that modern devices "can have different settings based on your environment and your specific type of hearing loss."
A budget option might be adequate for occasional use or mild hearing loss. But if you rely on your hearing aids all day, every day, or have complex hearing needs, investing in better technology could dramatically improve your quality of life. As Bovenzi suggests, cheaper models may sacrifice some of the audio quality you'll experience with higher-end versions, which can make the difference between hearing sounds and truly understanding conversations.
(back to top)
Dr. Cory Bovenzi, otolaryngologist in Denver
Meaghan Reed, clinical director of audiology at Mass Eye and Ear in Boston.
Dr. Michael Yong, otolaryngologist and neurorhinologist at the Pacific Neuroscience Institute in Santa Monica, Calif.
Our health content is for informational purposes only and is not intended as professional medical advice. Consult a medical professional on questions about your health.
(back to top)
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNN
40 minutes ago
- CNN
Sliding vaccine rates hang over vote on CDC director nominee as US measles cases hit dangerous milestone
The US Centers for Disease Control and Prevention on Wednesday tallied the highest number of US measles cases since the disease was declared eliminated a quarter-century ago, just as a key Senate committee split the vote to advance President Donald Trump's nominee to lead the public health agency. There have been more measles cases in the US this year than any other since the disease was declared eliminated a quarter-century ago, according to CDC data, with at least 1,288 confirmed cases. Just halfway through the year, the case tally has already surpassed the previous record from 2019, when there were a total of 1,274 cases. And it's well above the average of about 180 measles cases that have been reported each year since the disease was declared eliminated in the US in 2000. CNN reported this new milestone on Saturday using data from the Johns Hopkins University Center for Outbreak Response Innovation, which updates its numbers more frequently than the CDC. HHS has not responded to CNN's request for comment about the measles milestone. Childhood vaccine coverage has been declining in the US, and the vast majority of measles cases this year – more than 90% – have been in people who were unvaccinated or whose vaccination status was unknown, according to the CDC. When the measles case count reached its previous record in 2019 – during the first Trump administration – both the CDC director and the secretary of the US Department of Health and Human Services at the time released statements emphasizing the safety and effectiveness of the measles-mumps-rubella (MMR) vaccine and encouraging Americans to get vaccinated. However, almost six months into Trump's second term, the CDC still does not have a director and HHS Secretary Robert F. Kennedy Jr. has a long and complicated history with measles vaccines. Concerns about vaccine skepticism were front and center Wednesday as members of the Senate Health, Education, Labor and Pensions Committee voted to advance President Donald Trump's nominee to lead the CDC, Dr. Susan Monarez, for a vote by the full Senate. Committee members voted 12-11 to move Monarez's nomination. All of the committee's Republicans backed the longtime immunologist and government scientist, who spoke in her confirmation hearing about restoring trust in the CDC and defended Kennedy's decision to replace the members of a federal panel of vaccine advisers. The vote puts Monarez one step closer to taking the helm at the public health agency, and she will now progress to a full Senate vote. HELP Chairman Sen. Bill Cassidy, a Louisiana Republican and a doctor, voted to advance Monarez's nomination but nodded to falling vaccine coverage and the ongoing measles outbreak. 'Dr. Monarez will work to modernize our data health systems, to improve public health coordination and response while protecting American sensitive health information,' Cassidy said. 'This is especially crucial as the nation combats reemerging public health threats like measles, which has taken three lives in the United States this year.' He continued: 'One that's not included but is tragic: A Canadian woman who was pregnant got exposed to measles and lost her child. [The ongoing outbreak has] hospitalized many more due to misinformation regarding the measles vaccine.' Cassidy publicly pressed Kennedy last month to delay a meeting of the health agency's new vaccine advisers — several of whom have expressed skepticism and safety concerns about long-approved immunizations — amid concerns about their biases. During Wednesday's meeting, Sen. Patty Murray, a Washington Democrat, called on the committee to hold a hearing about the ongoing measles outbreak and Kennedy's shakeup of vaccine oversight. 'I am concerned because this committee, it feels like, has all but abandoned its serious oversight of this crisis,' she said. 'We haven't had a hearing on the record-breaking number of measles outbreaks or a hearing on how the CDC vaccine panel is now stacked with people who are actually not vetted, and all the previous board members, every single one of them, was removed with no credible explanation.' There needs to be congressional oversight of these actions, Murray said after casting a vote against Monarez. 'I really do hope that Dr. Monarez will defy my expectations. I hope she will stand up for science and put public health first. But again, I hope I have hoped that for others, and here we are today,' she said. Some health experts have emphasized the importance of vaccination rates and their trepidation about precedents being set under Kennedy's leadership of HHS. 'It is no surprise that the most widespread measles outbreak affecting the United States in a generation has occurred under Secretary Kennedy's watch,' Dr. Richard Besser, president and CEO of the Robert Wood Johnson Foundation and former acting director of the CDC, said in a statement Wednesday. 'His decades-long campaign to discredit vaccines at every turn, which has continued unabated during his time as health secretary, directly contributes to the alarming decline in routine childhood vaccination rates in our country that is resulting in more frequent outbreaks of vaccine-preventable diseases,' he said. 'In addition, the dramatic funding cuts to public health will mean that small outbreaks will grow and spread.' Three people have died of measles in the US this year – two children in Texas and one adult in New Mexico, all of whom were unvaccinated – matching the total number of US measles deaths from the previous two and a half decades. 'I worry that even more children will be forced to pay with their lives or health because of Secretary Kennedy's malfeasance,' Besser said. 'As a pediatrician, I strongly encourage all parents to talk to their healthcare providers, listen to their local public health officials, and learn the facts about measles vaccines, which are incredibly effective and safe.' The MMR vaccine is highly effective. One dose offers 93% protection against measles, and two doses are 97% effective, according to the CDC. 'Vaccines work—full stop. They are one of the most powerful tools we have to protect patients, families and entire communities. We can prevent diseases through vaccines, but too many diseases that we once had under control are starting to reappear because people are choosing to delay or skip immunization,' Dr. Jennifer Brull, president of the American Academy of Family Physicians, said in a statement. 'There's a lot of confusion around vaccinations, but patients don't have to navigate this alone. Family physicians, pediatricians, pharmacists and other public health workers can help patients wade through all the information and cut through the noise,' she said. 'The bottom line is vaccines are safe, effective and save lives. It's critical that we continue to protect not just individual families, but the health of our entire nation.'


CNN
41 minutes ago
- CNN
Biden's physician refuses to answer questions from Republicans in House probe of former president's mental fitness
Joe Biden's White House physician on Wednesday declined to answer questions during a closed-door deposition with the House Oversight Committee, invoking his Fifth Amendment right as the Republican-led panel pushes forward in its probe of the former president's mental fitness and decline. While Dr. Kevin O'Connor appeared on Capitol Hill Wednesday, his attorneys said he 'respectfully declined to answer any questions' from the panel, which had refused to limit the scope of the interview – imperiling, they said, his physician-patient privilege. 'Revealing confidential patient information would violate the most fundamental ethical duty of a physician, could result in revocation of Dr. O'Connor's medical license, and would subject Dr. O'Connor to potential civil liability. Dr. O'Connor will not violate his oath of confidentiality to any of his patients, including President Biden,' O'Connor's attorneys said in a statement on his behalf. The investigation is the latest front in the GOP push to expose alleged cover-ups by Biden and his inner circle that had fallen dormant in the last Congress. Republicans say the interviews are critical to supporting claims of the former president's cognitive decline in the final days of his administration. Democrats, meanwhile, have dismissed the probe in its entirety as a political stunt. The panel subpoenaed O'Connor in June after first seeking a voluntary interview, and has requested interviews with nearly a dozen former White House aides in recent months. But the interviews, which began as voluntary appearances, have grown increasingly contentious after President Donald Trump waived executive privilege for the physician and others. O'Connor's team on Wednesday argued the panel should pause its probe until the Department of Justice concludes its separate criminal investigation into his predecessor's actions and use of the autopen, which Trump had ordered in a memorandum. 'We believe that the Committee should hold its investigation in abeyance until any criminal investigation has concluded,' O'Connor's team said. A committee aide pushed back on the notion that O'Connor pleaded the Fifth Amendment because of doctor-patient privilege, arguing the physician did not answer any questions beyond his name. Invoking the Fifth Amendment is typically done to avoid answering specific questions. Though it can be perceived by the public as a way of avoiding accountability, the US Supreme Court has long regarded the right against self-incrimination as a venerable part of the Constitution and, in legal proceedings, tried to ensure that a witness' silence not be viewed as evidence of guilt. Following O'Connor's departure, House Oversight Chair James Comer accused the doctor of wanting to 'conceal the truth.' 'The American people demand transparency, but Dr. O'Connor would rather conceal the truth. Dr. O'Connor took the Fifth when asked if he was told to lie about President Biden's health and whether he was fit to be President of the United States,' the Kentucky Republican said in a statement. The committee still has multiple interviews scheduled throughout the summer. Unable to invoke executive privilege to avoid answering questions, some witnesses have already sought to stave them off. Former Biden aide Anthony Bernal withdrew from a voluntary interview last month after the White House counsel's office made clear that privilege would be waived. Comer then subpoenaed Bernal for his testimony. At least one interview has already led to a dispute over testimony. Comer claimed that Neera Tanden, Biden's director of the Domestic Policy Council, told the committee during her voluntary closed-door interview last month that she had 'no visibility' into how the approval for Biden's autopen signatures worked – a point that Republicans have latched onto. A Democratic committee official, however, swiftly pushed back on that characterization, saying that Tanden 'repeatedly and explicitly confirmed that she received President Biden's written sign-off on every executive action she presented him with.' 'Any other characterization is a distortion of the testimony,' the official told CNN at the time. Interview transcripts from Tanden's appearance have not yet been released. The top Democrat on the House Oversight Committee, Rep. Robert Garcia of California, criticized the Republican effort, saying the GOP is more concerned with the former president's health than their constituents' access to health care. 'The only person's health that Republicans care about is Joe Biden's – even as 17 million Americans lose access to affordable health care thanks to their big budget betrayal,' Garcia said in a statement. One Biden ally accused Republicans of playing politics with the congressional inquiry. 'It's an attempt to smear and embarrass. And their hope is for just one tiny inconsistency between witnesses to appear so that Trump's DOJ can prosecute his political opponents and continue his campaign of revenge,' the person told CNN.


CNN
42 minutes ago
- CNN
Sliding vaccine rates hang over vote on CDC director nominee as US measles cases hit dangerous milestone
The US Centers for Disease Control and Prevention on Wednesday tallied the highest number of US measles cases since the disease was declared eliminated a quarter-century ago, just as a key Senate committee split the vote to advance President Donald Trump's nominee to lead the public health agency. There have been more measles cases in the US this year than any other since the disease was declared eliminated a quarter-century ago, according to CDC data, with at least 1,288 confirmed cases. Just halfway through the year, the case tally has already surpassed the previous record from 2019, when there were a total of 1,274 cases. And it's well above the average of about 180 measles cases that have been reported each year since the disease was declared eliminated in the US in 2000. CNN reported this new milestone on Saturday using data from the Johns Hopkins University Center for Outbreak Response Innovation, which updates its numbers more frequently than the CDC. HHS has not responded to CNN's request for comment about the measles milestone. Childhood vaccine coverage has been declining in the US, and the vast majority of measles cases this year – more than 90% – have been in people who were unvaccinated or whose vaccination status was unknown, according to the CDC. When the measles case count reached its previous record in 2019 – during the first Trump administration – both the CDC director and the secretary of the US Department of Health and Human Services at the time released statements emphasizing the safety and effectiveness of the measles-mumps-rubella (MMR) vaccine and encouraging Americans to get vaccinated. However, almost six months into Trump's second term, the CDC still does not have a director and HHS Secretary Robert F. Kennedy Jr. has a long and complicated history with measles vaccines. Concerns about vaccine skepticism were front and center Wednesday as members of the Senate Health, Education, Labor and Pensions Committee voted to advance President Donald Trump's nominee to lead the CDC, Dr. Susan Monarez, for a vote by the full Senate. Committee members voted 12-11 to move Monarez's nomination. All of the committee's Republicans backed the longtime immunologist and government scientist, who spoke in her confirmation hearing about restoring trust in the CDC and defended Kennedy's decision to replace the members of a federal panel of vaccine advisers. The vote puts Monarez one step closer to taking the helm at the public health agency, and she will now progress to a full Senate vote. HELP Chairman Sen. Bill Cassidy, a Louisiana Republican and a doctor, voted to advance Monarez's nomination but nodded to falling vaccine coverage and the ongoing measles outbreak. 'Dr. Monarez will work to modernize our data health systems, to improve public health coordination and response while protecting American sensitive health information,' Cassidy said. 'This is especially crucial as the nation combats reemerging public health threats like measles, which has taken three lives in the United States this year.' He continued: 'One that's not included but is tragic: A Canadian woman who was pregnant got exposed to measles and lost her child. [The ongoing outbreak has] hospitalized many more due to misinformation regarding the measles vaccine.' Cassidy publicly pressed Kennedy last month to delay a meeting of the health agency's new vaccine advisers — several of whom have expressed skepticism and safety concerns about long-approved immunizations — amid concerns about their biases. During Wednesday's meeting, Sen. Patty Murray, a Washington Democrat, called on the committee to hold a hearing about the ongoing measles outbreak and Kennedy's shakeup of vaccine oversight. 'I am concerned because this committee, it feels like, has all but abandoned its serious oversight of this crisis,' she said. 'We haven't had a hearing on the record-breaking number of measles outbreaks or a hearing on how the CDC vaccine panel is now stacked with people who are actually not vetted, and all the previous board members, every single one of them, was removed with no credible explanation.' There needs to be congressional oversight of these actions, Murray said after casting a vote against Monarez. 'I really do hope that Dr. Monarez will defy my expectations. I hope she will stand up for science and put public health first. But again, I hope I have hoped that for others, and here we are today,' she said. Some health experts have emphasized the importance of vaccination rates and their trepidation about precedents being set under Kennedy's leadership of HHS. 'It is no surprise that the most widespread measles outbreak affecting the United States in a generation has occurred under Secretary Kennedy's watch,' Dr. Richard Besser, president and CEO of the Robert Wood Johnson Foundation and former acting director of the CDC, said in a statement Wednesday. 'His decades-long campaign to discredit vaccines at every turn, which has continued unabated during his time as health secretary, directly contributes to the alarming decline in routine childhood vaccination rates in our country that is resulting in more frequent outbreaks of vaccine-preventable diseases,' he said. 'In addition, the dramatic funding cuts to public health will mean that small outbreaks will grow and spread.' Three people have died of measles in the US this year – two children in Texas and one adult in New Mexico, all of whom were unvaccinated – matching the total number of US measles deaths from the previous two and a half decades. 'I worry that even more children will be forced to pay with their lives or health because of Secretary Kennedy's malfeasance,' Besser said. 'As a pediatrician, I strongly encourage all parents to talk to their healthcare providers, listen to their local public health officials, and learn the facts about measles vaccines, which are incredibly effective and safe.' The MMR vaccine is highly effective. One dose offers 93% protection against measles, and two doses are 97% effective, according to the CDC. 'Vaccines work—full stop. They are one of the most powerful tools we have to protect patients, families and entire communities. We can prevent diseases through vaccines, but too many diseases that we once had under control are starting to reappear because people are choosing to delay or skip immunization,' Dr. Jennifer Brull, president of the American Academy of Family Physicians, said in a statement. 'There's a lot of confusion around vaccinations, but patients don't have to navigate this alone. Family physicians, pediatricians, pharmacists and other public health workers can help patients wade through all the information and cut through the noise,' she said. 'The bottom line is vaccines are safe, effective and save lives. It's critical that we continue to protect not just individual families, but the health of our entire nation.'